Latest updates

Displaying 1 - 10 of 82

DME A/B MAC general documentation requirements collaborative webinar

Join our DME A/B MAC collaborative webinar related to Medicare's criteria for documentation requirements on March 18.

DME A/B MAC general documentation requirements collaborative webinar

Join our DME A/B MAC collaborative webinar related to Medicare's criteria for documentation requirements on March 18.

Process for pathology, laboratory, and other codes

Avoid negative impacts to your claims by providing the medical records for the laboratory, pathology and other codes claims submissions indicated in this article. First Coast requests specific…

Avoiding hospice claim rejects

Providers billing Medicare should determine if a patient is enrolled in hospice before billing Medicare Part A. This article has tips on checking patient eligibility and avoiding hospice claim…

NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy

Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…

NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy

Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for…

Current processing issues for Part A and Part B

This table displays Part A and Part B processing issues that are being worked currently or have been resolved recently.

MLN Connects for January 22, 2026

This edition includes information on E/M and intravitreal injections billing, vagus nerve stimulation NCD, telehealth, and more.

MLN Connects for January 22, 2026

This edition includes information on E/M and intravitreal injections billing, vagus nerve stimulation NCD, telehealth, and more.

Current processing issues for Part A and Part B

This table displays Part A and Part B processing issues that are being worked currently or have been resolved recently.